| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Jun-08 | 31-Mar-08 | | Total Revenue | 332,010 | 350,995 | 1,574,599 | 1,602,349 | | Cost of Revenue | 123,609 | 120,020 | 864,893 | 862,414 | | | Gross Profit | 208,401 | 230,975 | 709,706 | 739,935 | | | Operating Expenses | | Research Development | 18,088 | 65,457 |
-
|
-
| | Selling General and Administrative | 195,847 | 128,816 | 547,962 | 590,988 | | Non Recurring | 1,056 | 11,600 | 354,005 |
-
| | Others | 26,534 | 46,883 | 187,646 | 78,935 | | | | Total Operating Expenses | 241,525 | 252,756 |
-
|
-
| | | | Operating Income or Loss | (33,124) | (21,781) | (379,907) | 70,012 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,874 | 308,424 | (91,062) | 22,543 | | Earnings Before Interest And Taxes | (31,097) | 287,910 | (465,989) | 99,000 | | Interest Expense | 1,464 | 1,498 | 14,526 | 12,851 | | Income Before Tax | (32,561) | 286,412 | (480,515) | 86,149 | | Income Tax Expense | (2,679) | 65,876 | (44,325) | 36,809 | | Minority Interest |
-
| 4,654 | 1,367 | 895 | | | | Net Income From Continuing Ops | (29,882) | 225,190 | (434,823) | 50,235 | | | Non-recurring Events | | Discontinued Operations | 1,238 | 2,227 | 13,226 | 2,581 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (28,644) | 227,417 | (421,597) | 52,816 | | Preferred Stock And Other Adjustments | 258 |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($28,386) | $227,417 | ($421,597) | $52,816 |
|
0.45% Nasdaq 
0.20%
Income Statement
